• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Magnifying glass with pills on blue
Pharma

Regulatory tracker: Leqembi scores FDA nod for subQ starter dose

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu , Kevin Dunleavy , Fraiser Kansteiner Jul 15, 2026 10:40am
milestone milestone pharmaceuticals

Huyabio's HDAC inhibitor scores in phase 3 melanoma study

Jul 14, 2026 10:48am
9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience

9 of the Top 10 Pharma Manufacturers Choose Redi Health

Brought to you by Redi Health
Floodgate floodgates

Cellares' recent wins have opened the floodgates for the IDMO

Jul 14, 2026 10:26am
Clinical Success Is No Longer One Number

Clinical Success Is No Longer One Number

Brought to you by Intelligencia AI
AstraZeneca

AstraZeneca buys lung cancer drug Zegfrovy from Dizal for $1.5B

Jul 14, 2026 9:57am
More News

Real Chemistry builds body of AI tools with Anatomi launch

Jul 14, 2026 7:23am

Insulet, Calm to fill mental health gaps in diabetes treatment

Jul 14, 2026 3:00am

FDA proposes to simplify registration of US drug manufacturing

Jul 13, 2026 11:37am

GSK to seek FDA approval for Jemperli in high-profile cancer use

Jul 13, 2026 10:50am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings